Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318306-09-000015
Filing Date
2009-05-19
Accepted
2009-05-19 17:23:39
Documents
5
Period of Report
2009-05-19

Document Format Files

Seq Description Document Type Size
1 FORM 10Q 033109 a10q-033109.htm 10-Q 674524
2 CEO CERTIFICATION ex_31-1.htm EX-31.1 16834
3 CFO CERTIFICATION ex_31-2.htm EX-31.2 16842
4 CEO CERTIFICATION ex_32-1.htm EX-32.1 5971
5 CFO CERTIFICATION ex_32-2.htm EX-32.2 5759
  Complete submission text file 0000318306-09-000015.txt   721549
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 09840403
SIC: 2834 Pharmaceutical Preparations